Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Liminal Biosciences Inc (LMNL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2017	12-2016	12-2015	12-2014	12-2006
Cash Flows From Operating Activities
Net Income	-92,596	-83,577	-44,463	N/A	N/A
Depreciation Amortization	3,530	2,454	1,908	N/A	N/A
Income taxes - deferred	-8,938	-4,697	-4,025	N/A	N/A
Other Working Capital	-15,521	-1,144	-759	N/A	N/A
Other Operating Activity	18,972	13,186	11,597	0	0
Operating Cash Flow	$-94,553	$-73,778	$-35,742	$N/A	$N/A

Cash Flows From Investing Activities
Change In Deposits	8,534	8,799	N/A	N/A	N/A
PPE Investments	-5,931	-10,637	-4,483	N/A	N/A
Net Acquisitions	N/A	10,191	-659	N/A	N/A
Purchase Sale Intangibles	-1,848	-1,094	-940	N/A	N/A
Other Investing Activity	-1,740	-877	-676	0	0
Investing Cash Flow	$863	$7,477	$-5,817	$N/A	$N/A

Cash Flows From Financing Activities
Debt Issued	39,123	22,664	N/A	N/A	N/A
Debt Repayment	-2,664	N/A	N/A	N/A	N/A
Common Stock Issued	41,352	45,890	46,005	N/A	N/A
Other Financing Activity	12,792	-2,898	-3,095	0	0
Financing Cash Flow	$90,603	$65,656	$42,910	$N/A	$N/A

Exchange Rate Effect	-492	-471	358	N/A	N/A
Beginning Cash Position	21,450	22,116	21,221	N/A	N/A
End Cash Position	17,870	20,999	22,930	N/A	N/A
Net Cash Flow	$-3,579	$-1,117	$1,709	$N/A	$N/A

Free Cash Flow
Operating Cash Flow	-94,553	-73,778	-35,742	N/A	N/A
Capital Expenditure	-5,931	-10,637	-4,483	N/A	N/A
Free Cash Flow	-100,483	-84,415	-40,224	0	0